AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 108 filers reported holding AVROBIO INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $40,000 | -68.5% | 30,300 | -8.5% | 0.00% | – |
| Q4 2021 | $127,000 | -36.2% | 33,100 | -7.0% | 0.00% | – |
| Q3 2021 | $199,000 | -37.0% | 35,600 | 0.0% | 0.00% | – |
| Q2 2021 | $316,000 | -12.2% | 35,600 | +25.4% | 0.00% | – |
| Q1 2021 | $360,000 | -9.1% | 28,400 | 0.0% | 0.00% | – |
| Q4 2020 | $396,000 | +7.0% | 28,400 | 0.0% | 0.00% | – |
| Q3 2020 | $370,000 | -29.4% | 28,400 | -5.3% | 0.00% | – |
| Q2 2020 | $524,000 | +18.6% | 30,000 | +5.6% | 0.00% | – |
| Q1 2020 | $442,000 | -22.7% | 28,400 | 0.0% | 0.00% | – |
| Q4 2019 | $572,000 | +42.6% | 28,400 | 0.0% | 0.00% | – |
| Q3 2019 | $401,000 | +57.9% | 28,400 | +82.1% | 0.00% | – |
| Q2 2019 | $254,000 | +10.9% | 15,600 | +50.0% | 0.00% | – |
| Q1 2019 | $229,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,191,676 | $16,612,000 | 8.00% |
| Aisling Capital Management LP | 1,009,779 | $14,076,000 | 2.42% |
| Burrage Capital Management LLC | 145,715 | $2,031,000 | 1.55% |
| Camber Capital Management LP | 3,133,333 | $43,679,000 | 1.53% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $4,399,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 655,874 | $9,143,000 | 0.81% |
| EMERALD ADVISERS, LLC | 1,009,212 | $14,068,000 | 0.47% |
| Penn Mutual Asset Management, LLC | 37,306 | $520,000 | 0.46% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 932,627 | $13,001,000 | 0.45% |
| MPM BioImpact LLC | 364,285 | $5,078,000 | 0.44% |